{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:31:48Z","timestamp":1787725908025,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":905,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Auckland Medical Research Fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.rmed.2010.11.001","type":"journal-article","created":{"date-parts":[[2010,11,27]],"date-time":"2010-11-27T04:47:30Z","timestamp":1290833250000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD"],"prefix":"10.1016","volume":"105","author":[{"given":"Lian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise F.B.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2010.11.001_bib1","first-page":"1","article-title":"Advanced glycosylation: chemistry, biology, and implication for diabetes and ageing","volume":"23","author":"Bucala","year":"1992","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.rmed.2010.11.001_bib2","series-title":"Post translational modifications of proteins","first-page":"53","article-title":"Advanced glycosylation end products","author":"Bucala","year":"1992"},{"key":"10.1016\/j.rmed.2010.11.001_bib3","first-page":"949","article-title":"The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmed.2010.11.001_bib4","first-page":"62","article-title":"Non-enzymatic glycation of peripheral nerve proteins in human diabetics","volume":"129","author":"Ryle","year":"1995","journal-title":"J Neurol Asci"},{"key":"10.1016\/j.rmed.2010.11.001_bib5","first-page":"108","article-title":"Renoprotective effects of a novel inhibitor of advanced glycation","volume":"44","author":"Forbes","year":"2001","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.rmed.2010.11.001_bib6","first-page":"45","article-title":"Reactive oxygen species mediate cellular damage in Alzheimer disease","volume":"1","author":"Perry","year":"1998","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.rmed.2010.11.001_bib7","first-page":"19","article-title":"AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?","volume":"2","author":"Dukic-Stefanovic","year":"2001","journal-title":"Biogerontology"},{"key":"10.1016\/j.rmed.2010.11.001_bib8","first-page":"1645","article-title":"The natural history of chronic airflow obstruction","volume":"1","author":"Fletcher","year":"1977","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.rmed.2010.11.001_bib9","first-page":"594","article-title":"Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers","volume":"4","author":"Nicholl","year":"1998","journal-title":"Mol Med"},{"issue":"8","key":"10.1016\/j.rmed.2010.11.001_bib10","first-page":"543","article-title":"Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts","volume":"7","author":"Daoud","year":"2001","journal-title":"Mol Med"},{"key":"10.1016\/j.rmed.2010.11.001_bib11","first-page":"14998","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation endproducts of proteins","volume":"267","author":"Neeper","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rmed.2010.11.001_bib12","first-page":"122","article-title":"Hyperglycaemia increases CML deposition, RAGE expression and NFkappaB activation in peripheral nerves","volume":"108","author":"Bierhaus","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.rmed.2010.11.001_bib13","first-page":"6957","article-title":"The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units","volume":"46","author":"Dattilo","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.rmed.2010.11.001_bib14","first-page":"889","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.rmed.2010.11.001_bib15","first-page":"475","article-title":"Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells","volume":"323","author":"Demling","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.rmed.2010.11.001_bib16","first-page":"822","article-title":"CD8+ T lymphocytes in the peripheral airways of smokers with chronic obstructive pulmonary disease","volume":"157","author":"Saetta","year":"1998","journal-title":"Am J Respir Crit Care"},{"issue":"3","key":"10.1016\/j.rmed.2010.11.001_bib17","first-page":"210","article-title":"Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology","volume":"162","author":"Mukherjee","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"issue":"9","key":"10.1016\/j.rmed.2010.11.001_bib18","first-page":"917","article-title":"Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease","volume":"181","author":"Ferhani","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2010.11.001_bib19","first-page":"479","article-title":"Lung level of HMBG1 is elevated in response to advanced glycation end product-enriched food in vivo","volume":"51","author":"Bartling","year":"2007","journal-title":"Mol Nutr Food Res"},{"issue":"12","key":"10.1016\/j.rmed.2010.11.001_bib20","first-page":"6474","article-title":"Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy","volume":"94","author":"Koschinsky","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rmed.2010.11.001_bib21","first-page":"261","article-title":"Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice","volume":"108","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmed.2010.11.001_bib22","first-page":"959","article-title":"Central role of RAGE-dependent neointimal expansion in arterial restenosis","volume":"111","author":"Sakaguchi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmed.2010.11.001_bib23","first-page":"1641","article-title":"Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response","volume":"113","author":"Liliensiek","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmed.2010.11.001_bib24","first-page":"G556","article-title":"The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock","volume":"291","author":"Raman","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.rmed.2010.11.001_bib25","first-page":"907","article-title":"RAGE mediates amyloidbeta peptide transport across the blood\u2013brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.rmed.2010.11.001_bib26","first-page":"1342","article-title":"RAGE axis: animal models and novel insights into the vascular complications of diabetes","volume":"24","author":"Naka","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.rmed.2010.11.001_bib27","first-page":"583","article-title":"A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis","volume":"172","author":"Englert","year":"2008","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.rmed.2010.11.001_bib28","first-page":"337","article-title":"Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types","volume":"39","author":"Queisser","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmed.2010.11.001_bib29","first-page":"1008","article-title":"Receptor for advanced glycation endproducts is a marker of type I cell injury in acute lung injury","volume":"173","author":"Uchida","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.11.001_bib30","first-page":"613","article-title":"Expression of S100A12 (EN-RAGE) in cystic fibrosis","volume":"58","author":"Foell","year":"2003","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.rmed.2010.11.001_bib31","first-page":"1437","article-title":"The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?","volume":"19","author":"Morbini","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.rmed.2010.11.001_bib32","first-page":"E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.rmed.2010.11.001_bib33","first-page":"1222","article-title":"Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice","volume":"172","author":"Yao","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rmed.2010.11.001_bib34","first-page":"44","article-title":"Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs)","volume":"87","author":"Dukic-Stefanovic","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.rmed.2010.11.001_bib35","first-page":"8870","article-title":"Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.rmed.2010.11.001_bib36","first-page":"4598","article-title":"Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine\/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB","volume":"276","author":"Liu","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.rmed.2010.11.001_bib37","first-page":"1","article-title":"RAGE (Receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation","volume":"7","author":"Sparvero","year":"2009","journal-title":"J Transl Med"},{"key":"10.1016\/j.rmed.2010.11.001_bib38","first-page":"1961","article-title":"Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia","volume":"14","author":"Wong","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.rmed.2010.11.001_bib39","first-page":"876","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.rmed.2010.11.001_bib40","first-page":"2792","article-title":"Diabetes associated sustained activation of the transcription factor nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.rmed.2010.11.001_bib41","first-page":"128","article-title":"Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences","volume":"13","author":"Higashimoto","year":"2008","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.rmed.2010.11.001_bib42","first-page":"753","article-title":"Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease","volume":"20","author":"Foschino Barbaro","year":"2007","journal-title":"Int J Immunopathol Pharmacol"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110004750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110004750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:04:29Z","timestamp":1760612669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611110004750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0954611110004750"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2010.11.001","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2010.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}